Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future

Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future is organized by National Comprehensive Cancer Network (NCCN),,Course opens: 07/14/2022,Course expires: 07/14/2023,,Description:,The goal of this program is to improve the knowledge and competence of learners in the optimal management of patients with renal cell carcinoma (RCC).,,Learning Objectives:,Upon completion of this activity, participants should be able to:,• Review clinical data and consensus guideline recommendations on systemic treatment approaches for patients with operable, advanced, or metastatic RCC,• Identify patients with RCC most likely to benefit from targeted and/or immune checkpoint inhibitor–based combination therapies based on risk and biomarker assessment, along with patient medical and treatment history,• Select optimal first-line treatment for individual patients with advanced or metastatic RCC, taking into consideration targeted and immune checkpoint inhibitor combination options, available clinical evidence, expert recommendations, and patient preferences,• Plan evidence-based and expert recommended therapeutic sequencing strategies for patients with RCC,• Manage specific disease-related complications or adverse events associated with currently approved monotherapies and therapy combinations for advanced RCC,• Select patients with RCC who may benefit from ongoing clinical trials based on tumor characteristics, previous treatment, and patient characteristics and preferences,,Additional details will be posted as soon as information is available.